tirzepatide and gastroparesis ๐งฌ GLP-1s Gastroparesis: What You Need to Know, GLP-1 receptor agonists (like semaglutide and tirzepatide) have revolutionized weight management and type 2 diabetes care. But as use has Independent Nurse - Diabetic gastroparesis:
Description
The cumulative incidence of clinical events was consistent across the two treatment strategies (Table 3 in the ESM)

PMID: 20673995

Naltrexone/bupropion for weight loss In medical weight loss, naltrexone/bupropion should not be viewed in isolation

Additionally, the reassuring safety findings further support the strong potential value of semaglutide in this population. Chronic kidney disease affects over 800 million people worldwide and is particularly prevalent among individuals with type 2 diabetes

The conclusion from the European Medicines Agency (EMA) affirms two studies that suggested the link back in December 2024
